Exome Asset Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.72M | Sell |
155,533
-9,963
| -6% | -$430K | 4.99% | 1 |
|
|
2025
Q1 | $5.72M | Sell |
165,496
-81,204
| -33% | -$2.81M | 5.09% | 1 |
|
|
2024
Q4 | $6.77M | Buy |
246,700
+35,700
| +17% | +$980K | 5.09% | 1 |
|
|
2024
Q3 | $5.37M | Buy |
211,000
+132,093
| +167% | +$3.36M | 3.63% | 3 |
|
|
2024
Q2 | $2M | Buy |
78,907
+30,100
| +62% | +$762K | 1.78% | 28 |
|
|
2024
Q1 | $1.51M | Sell |
48,807
-16,306
| -25% | -$504K | 1.29% | 35 |
|
|
2023
Q4 | $2.63M | Buy |
+65,113
| New | +$2.63M | 2.6% | 15 |
|